Chugai Pharma’s phase III HAVEN 3 study evaluating emicizumab meets primary endpoint
Chugai Pharmaceutical has announced that the primary endpoint has been met for the global phase III HAVEN 3 (NCT02847637) study evaluating emicizumab (ACE910) subcutaneous...
Adocia announces positive results from phase 1 study of BioChaperone Glucagon
Adocia a clinical stage biopharmaceutical company focused on diabetes treatment with innovative formulations of approved proteins, announced top-line results of a phase 1 study...
Promentis Pharmaceuticals Commences Phase 1 Study For SXC-2023 Targeting Neuropsychiatric Disorders
Promentis Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing innovative therapies for neuropsychiatric disorders, today announced that it has commenced a Phase 1 single ascending...
Sobi begins phase 3 study evaluating safety and efficacy of anakinra to treat Still’s disease
Swedish Orphan Biovitrum AB (Sobi) has announced that the first patient has been randomised in the phase 3 study anaSTILLs, to evaluate efficacy and...
Abivax Enrolls First Ulcerative Colitis Patient In New ABX464 Proof-Of-Concept Clinical Trial
ABIVAX announced the enrolment of the first patient in the ABX464-101 proof-of-concept study of its lead product candidate ABX464 in subjects suffering from moderate-to-severe...
Wellthy Therapeutics conducts first made-in-India ‘digital pill’ clinical trial for diabetes
Wellthy Therapeutics a digital therapeutics company that uses artificial intelligence (AI) and patient centric design to improve patient outcomes is now conducting the first...
Webflow Mobile App Launch
WebflowTM is a comprehensive customer support center which provides PCI clients real-time, 24/7 access to a wide range of reports and information regarding the...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...
